From November 25 to 29, 2024, Zhuhai United Laboratories Co., Ltd. passed the online GMP inspection conducted by Mexico』s official agency COFEPRIS. The inspection covered the sterile bulk medicines: ceftriaxone sodium and cefotaxime sodium. This is the eighth time since 2013 that Zhuhai United Laboratories Co., Ltd. has passed a COFEPRIS GMP inspection. Following the successful on-site GMP inspection by Brazil earlier this year in April, it reflects the company』s continued commitment and expansion to the South American market, further strengthening its competitiveness and influence in the international pharmaceutical market.